FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma
oleh: Elio Adib, Talal El‐Zarif, Rohit K. Jain, William P. Skelton IV, Dory Freeman, Catherine Curran, Elie W. Akl, Amin H. Nassar, Praful Ravi, Charlene Mantia, David J. Kwiatkowski, Toni K. Choueiri, Guru P. Sonpavde
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-03-01 |
Deskripsi
Subjek
biomarkers; bladder cancer; enfortumab vedotin; genomics; targeted therapy